Literature DB >> 15058007

Cell responses to BMP-2 and IGF-I released with different time-dependent profiles.

A T Raiche1, D A Puleo.   

Abstract

During wound healing, growth factors are expressed in time-dependent amounts. Constant delivery of biomolecules, however, is often used to influence cell and tissue behavior. In the present studies, a crosslinked gelatin-coating system was used to deliver bone morphogenetic protein 2 (BMP-2) or insulin-like growth factor (IGF-I) to three types of mesenchymal cells with three temporally varying release profiles. The "early" delivery profile released most of the growth factor within the first 2 days. The "pseudo-zero-order" profile approximated constant rate of delivery for about 5 days. The "late" delivery profile released most of the growth factor after about 5 days. Early delivery of IGF-I had the greatest effect on mitogenesis of SaOS-2 human osteosarcoma cells with a secondary effect noted nearly 5 days after delivery was completed. Late delivery of BMP-2 resulted in greatest alkaline phosphatase (AP) activity in mouse pluripotent C3H10T1/2 cells. Rat bone marrow stromal cells (BMCs) responded to all delivery profiles of BMP-2, with the duration of elevated AP activity increasing as the amount of BMP-2 delivered increased. In addition to an early increase in AP activity, late release also stimulated BMCs over a longer portion of the culture period. BMCs responded similarly to SaOS-2 cells when seeded on early IGF-I delivery coatings, increasing AP activity after delivery had ended. Overall, these studies further show the importance of delivery profile, specifically the characteristics of time and concentration, on cell and tissue responses. Copyright 2004 Wiley Periodicals, Inc. J Biomed Mater Res 69A: 342-350, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15058007     DOI: 10.1002/jbm.a.30006

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  12 in total

1.  Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation.

Authors:  Sungwoo Kim; Yunqing Kang; Chad A Krueger; Milan Sen; John B Holcomb; Di Chen; Joseph C Wenke; Yunzhi Yang
Journal:  Acta Biomater       Date:  2012-01-18       Impact factor: 8.947

Review 2.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-02-19       Impact factor: 6.389

Review 3.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

4.  Optimal Control of One-dimensional Cellular Uptake in Tissue Engineering.

Authors:  Masako Kishida; Ashlee N Ford Versypt; Daniel W Pack; Richard D Braatz
Journal:  Optim Control Appl Methods       Date:  2013-11       Impact factor: 2.530

5.  Comparison of bone morphogenetic protein-2 and osteoactivin for mesenchymal cell differentiation: effects of bolus and continuous administration.

Authors:  Oneida A Arosarena; Fabiola E Del Carpio-Cano; Raul A Dela Cadena; Mario C Rico; Emeka Nwodim; Fayez F Safadi
Journal:  J Cell Physiol       Date:  2011-11       Impact factor: 6.384

6.  Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering.

Authors:  Xiaoqin Wang; Esther Wenk; Xiaohui Zhang; Lorenz Meinel; Gordana Vunjak-Novakovic; David L Kaplan
Journal:  J Control Release       Date:  2008-11-17       Impact factor: 9.776

7.  pHEMA-nHA encapsulation and delivery of vancomycin and rhBMP-2 enhances its role as a bone graft substitute.

Authors:  Xinning Li; Jianwen Xu; Tera M Filion; David C Ayers; Jie Song
Journal:  Clin Orthop Relat Res       Date:  2013-08       Impact factor: 4.176

8.  Sustained and localized in vitro release of BMP-2/7, RANKL, and tetracycline from FlexBone, an elastomeric osteoconductive bone substitute.

Authors:  Jianwen Xu; Xinning Li; Jane B Lian; David C Ayers; Jie Song
Journal:  J Orthop Res       Date:  2009-10       Impact factor: 3.494

9.  The use of N-terminal immobilization of PTH(1-34) on PLGA to enhance bioactivity.

Authors:  Jessica L Sharon; David A Puleo
Journal:  Biomaterials       Date:  2008-04-29       Impact factor: 12.479

10.  Effect of coadministration of vancomycin and BMP-2 on cocultured Staphylococcus aureus and W-20-17 mouse bone marrow stromal cells in vitro.

Authors:  A H Nguyen; S Kim; W J Maloney; J C Wenke; Y Yang
Journal:  Antimicrob Agents Chemother       Date:  2012-05-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.